doi: 10.3389/fmed.2024.1442525 Received 02 June 2024 Accepted 30 October 2024 Published 14 November 2024 Volume 11 - 2024 Edited by Thierry Thvenot, University Hospital of Besanon, France Reviewed by Qianqian Zhang, First Affiliated Hospital of Anhui Medical University, China Jonathan Soldera, University of Caxias do Sul, Brazil Juan Pablo Roblero, Clinical Hospital of the University of Chile, Chile Updates Copyright 2024 Philips
Fat-soluble vitamins like D3 are particularly vulnerable because their absorption depends on dietary fat, which many people on GLP-1s are also eating less of
TB-500 Although BPC-157 and TB-500 are often grouped together, they are not the same peptide
Bariatric surgery patients also have improved health outcomes: a recent retrospective cohort study demonstrated that the incidence of extended major adverse cardiovascular events was 8% lower in patients with established cardiovascular disease who received bariatric surgery compared to their age, sex, and history matched control
If you, or someone you care for, is taking GLP-1s and you notice symptoms such as severe, persistent stomach pain that may radiate to the back and may be accompanied by nausea and vomiting, then we advise you speak to a healthcare professional and report it via our Yellow Card scheme. Mounjaro Research published by University College London (UCL) earlier this month estimates that 1.6 million in England, Wales and Scotland used drugs such as Wegovy and Mounjaro to help lose weight between early 2024 and early 2025
JAMA (2014) 311(17):177886
/assets/images/provider/photos/2840805.png)
